Skip to main content

Mitochondria and Trypanosomatids: Targets and Drugs

Pharmaceutical Research volume 28, Article number: 2758 (2011) Cite this article

ABSTRACT

The family Trypanosomatidae, flagellated parasitic protozoa, is responsible for important infectious diseases in humans: sleeping sickness, Chagas diseases and leishmaniasis. Currently, development of effective vaccines against these parasites remains an unrealized goal, and clinical management is based on chemotherapeutics. Cost, toxicity and resistance problems of conventional drugs result in an urgent need to identify and develop new therapeutic alternatives. The sound understanding of parasites, biology is key for identifying novel lead structures and new drug targets. This article reviews current knowledge about mitochondrial drug targets and existing drugs against Trypanosoma and Leishmania. In the past, several targets in trypanosomatid mitochondria (electron transport chain, kDNA and topoisomerases, tRNA import and fatty acid synthesis) have been identified. It has been suggested that inhibition of certain targets is involved in triggering apoptosis by impairment of mitochondrial membrane potential and/or production of reactive oxygen species. The inhibitory mechanism of approved drugs, such as pentamidine, nifurtimox, artemisinin and atovaquone, is described in parallel with others products from preclinical studies. In spite of the large amount of genetic information, the analysis of the phenotype of the trypanosomatid mitochondrion in different life stages will remain a useful tool to design new active compounds with selective toxicity against these parasites.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

Abbreviations

DIM:

3,3′diindolylmethane

ETC:

electron transport chain

FAS:

fatty acid synthesis

FRD:

fumarate reductase

gRNAs:

short transcripts RNA

HAT:

Human African Trypanosomiasis

kDNA:

kinetoplastid DNA

MMP:

mitochondrial membrane potential

NADH:

nicotinamide adenine dinucleotide

NTDs:

neglected tropical diseases

PCD:

programmed cell death

RIC:

rNA import complex

ROS:

reactive oxygen species

TAO:

Trypanosoma alternative oxidase

tRNA:

transcription DNA

REFERENCES

  1. Caffrey CR, Steverding D. Recent initiatives and strategies to developing new drugs for tropical parasitic diseases. Expert Opin Drug Discov. 2008;3:173–86.

    Article  CAS  Google Scholar 

  2. Souza W. An introduction to the structural organization of parasitic protozoa. Curr Pharm Design. 2008;14:822–38.

    Article  Google Scholar 

  3. Scheffler IE. Mitochondria make a comeback. Adv Drug Deliv Rev. 2001;49:3–26.

    PubMed  Article  CAS  Google Scholar 

  4. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol. 2009;19:57–66.

    PubMed  Article  CAS  Google Scholar 

  5. Schneider A. Unique aspects of mitochondrial biogenesis in trypanosomatids. Int J Parasitol. 2001;31:1403–15.

    PubMed  Article  CAS  Google Scholar 

  6. Souza W, Attias M, Rodríguez JCF. Particularities of mitochondrial structure in parasitic protists (Apicomplexa and Kinetoplastida). Int J Biochem Cell Biol. 2009;41:2069–80.

    PubMed  Article  Google Scholar 

  7. Mather MW, Henry KW, Vaidya AB. Mitochondrial drug targets in apicomplexan parasites. Curr Drug Targets. 2007;8:49–60.

    PubMed  Article  CAS  Google Scholar 

  8. Monzote L, Gille L. Mitochondria as a promising antiparasitic target. Curr Clin Pharmacol. 2010;5:55–66.

    PubMed  Article  CAS  Google Scholar 

  9. Sen N, Majumder K. Mitochondrion of protozoa parasite emerges as potent therapeutic target: exciting drugs are on the horizon. Curr Pharm Design. 2008;14:839–46.

    Article  CAS  Google Scholar 

  10. Mehta A, Shaha C. Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity. J Biol Chem. 2004;279:11798–813.

    PubMed  Article  CAS  Google Scholar 

  11. Brun R, Krassner SM. Quantitative ultrastructural investigations of mitochondrial development in Leishmania donovani during transformation. J Protozool. 1976;23:493–7.

    PubMed  CAS  Google Scholar 

  12. Attardi G, Schatz G. The biogenesis of mitochondria. Annu Rev Cell Biol. 1988;4:289–333.

    PubMed  Article  CAS  Google Scholar 

  13. Riou G, Paoletti C. Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. J Mol Biol. 1967;28:377–82.

    PubMed  Article  CAS  Google Scholar 

  14. Shapiro TA, Showalter AF. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles. Mol Cell Biol. 1994;14:5891–7.

    PubMed  CAS  Google Scholar 

  15. Werbovetz KA. Promising therapeutic targets for antileishmanial drugs. Expert Opin Ther Targets. 2002;6:407–22.

    PubMed  Article  CAS  Google Scholar 

  16. Barrett MP, Burchmore MP, Stich A. The trypanosomiasis. Lancet. 2003;362:1469–80.

    PubMed  Article  Google Scholar 

  17. Buckner FS, Griffin JH, Wilson AJ, Van Voorhis WC. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob Agents Chemother. 2001;45:1210–5.

    PubMed  Article  CAS  Google Scholar 

  18. Worthen C, Jensen BC, Parson M. Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei. PLoS Neglect Trop Dis. 2010;4:e678.

    Article  Google Scholar 

  19. Chen M, Bennedsen M, Zhai L, Kharazmi A. Purification and enzymatic activity of an NADH-fumarate reductase and other mitochondrial activities of Leishmania parasites. APMIS. 2001;109:801–8.

    PubMed  Article  CAS  Google Scholar 

  20. Sen N, Banerjee B, Gupta SS, Das BB, Ganguly A, Majumder HK. Leishmania donovani: dyskinetoplastid cells survive and proliferate in the presence of pyruvate and uridine but do not undergo apoptosis after treatment with camptothecin. Exp Parasitol. 2007;115:215–9.

    PubMed  Article  CAS  Google Scholar 

  21. Chakraborty B, Biswas S, Mondal S, Bera T. Stage specific developmental changes in the mitochondrial and surface membrane associated redox systems of Leishmania donovani promastigote and amastigote. Biochem (Moscow). 2010;75:494–504.

    Article  CAS  Google Scholar 

  22. McConville MJ, de Souza D, Saunders E, Likic VA, Naderer T. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol. 2007;23:368–75.

    PubMed  Article  CAS  Google Scholar 

  23. Naderer T, McConville MJ. The Leishmania-macrophage interaction: a metabolic perspective. Cell Microbiol. 2008;10:301–8.

    PubMed  Article  CAS  Google Scholar 

  24. Dey R, Meneses C, Salotra P, et al. Characterization of a Leishmania stage-specific mitochondrial membrane protein enhances the activity of cytochrome c oxidase and its role in virulence. Mol Microbiol. 2010;77:399–414.

    PubMed  Article  Google Scholar 

  25. Abrahamsen MS, Templeton TJ, Enomoto S, et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science. 2004;304:441–5.

    PubMed  Article  CAS  Google Scholar 

  26. Vaidya AB. Mitochondrial and plastid functions as antimalarial drug targets. Curr Drug Targets Infect Disord. 2004;4:11–23.

    PubMed  Article  CAS  Google Scholar 

  27. Santhamma KR, Bhaduri A. Characterization of the respiratory chain of Leishmania donovani promastigotes. Mol Biochem Parasitol. 1995;75:43–53.

    PubMed  Article  CAS  Google Scholar 

  28. Turrens JF. Possible role of the NADH-fumarate reductase in superoxide anion and hydrogen peroxide production in Trypanosoma brucei. Mol Biochem Parasitol. 1987;25:55–60.

    PubMed  Article  CAS  Google Scholar 

  29. Srivastava IK, Rottenberg H, Vaidya AB. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem. 1997;272:3961–6.

    PubMed  Article  CAS  Google Scholar 

  30. Speijer D, Breek CK, Muijsers AO, et al. The sequence of a small subunit of cytochrome c oxidase from Crithidia fasciculate which is homologous to mammalian subunit IV. FEBS Lett. 1996;381:123–6.

    PubMed  Article  CAS  Google Scholar 

  31. Horvath A, Berry EA, Huang LS, Maslov DA. Leishmania tarentolae: a parallel isolation of cytochrome bc(1) and cytochrome c oxidase. Exp Parsitol. 2000;96:160–7.

    Article  CAS  Google Scholar 

  32. Zikova A, Panigrahi AK, Uboldi AD, Dalley RA, Handman E, Stuart K. Structural and functional association of Trypanosoma brucei MIX protein with cytochrome c oxidase complex. Eukaryot Cell. 2008;7:1994–2003.

    PubMed  Article  CAS  Google Scholar 

  33. Chaudhuri M, Ott RD, Hill GC. Trypanosome alternative oxidase: from molecule to function. Trends Parasitol. 2006;22:484–91.

    PubMed  Article  CAS  Google Scholar 

  34. Clarkson AB, Bienen EJ, Pollakis G, Grady RW. Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. J Biol Chem. 1989;264:17770–6.

    PubMed  CAS  Google Scholar 

  35. Das BB, Sengupta T, Ganguly A, Majumder HK. Topoisomerases of kinetoplastid parasites: why so fascinating? Mol Microbiol. 2006;62:917–27.

    PubMed  Article  CAS  Google Scholar 

  36. Reguera RM, Redondo CM, Gutierrez de Prado R, Pérez-Pertejo Y, Balaña-Fouce R. DNA topoisomerase I from parasitic protozoa: a potential target for chemotherapy. Biochim Biophys Acta. 2006;1759:117–31.

    PubMed  CAS  Google Scholar 

  37. Motta MCM. Kinetoplast as a potential chemotherapeutic target of trypanosomatids. Curr Pharm Des. 2008;14:847–54.

    PubMed  Article  CAS  Google Scholar 

  38. Bodley AL, McGarry MW, Shapiro TA. Drug cytotoxicity assay for African Trypanosomes and Leishmania Species. J Infect Dis. 1995;172:1157–9.

    PubMed  Article  CAS  Google Scholar 

  39. Schneider A, Marechal-Drouard L. Mitochondrial tRNA import: are there distinct mechanism? Trends Cell Biol. 2000;10:509–13.

    PubMed  Article  CAS  Google Scholar 

  40. Hancock K, Hajduk SL. The mitochondrial tRNAs of Trypanosoma brucei are nuclear encoded. J Biol Chem. 1990;265:19208–15.

    PubMed  CAS  Google Scholar 

  41. Battacharyya SN, Adhya S. The complexity of mitochondrial tRNA import. RNA Biol. 2004;1:84–8.

    Article  Google Scholar 

  42. Adhya S. Leishmania mitochondrial tRNA importers. Int J Biochem Cell Biol. 2008;40:2681–5.

    PubMed  Article  CAS  Google Scholar 

  43. Lee SH, Stephens JL, Paul KS, Englund PT. Fatty acid synthesis by elongases in trypanosomes. Cell. 2006;126:691–9.

    PubMed  Article  CAS  Google Scholar 

  44. Morita YS, Paul KS, Englund PT. Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors. Science. 2000;288:140–3.

    PubMed  Article  CAS  Google Scholar 

  45. Stephens JL, Lee SH, Paul KS, Englund PT. Mitochondrial fatty acid synthesis in Trypanosoma brucei. J Biol Chem. 2007;282:4427–36.

    PubMed  Article  CAS  Google Scholar 

  46. Guler JL, Kriegova E, Smith TK, Lukes J, Englund PT. Mitochondrial fatty acid synthesis is required for normal mitochondrial morphology and function in Trypanosoma brucei. Mol Microbiol. 2008;67:1125–42.

    PubMed  Article  CAS  Google Scholar 

  47. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol. 2003;126:129–42.

    PubMed  Article  CAS  Google Scholar 

  48. Gottlieb RA. Mitochondrial signaling in apoptosis: mitochondrial daggers to the breaking heart. Basic Res Cardiol. 2003;98:242–9.

    PubMed  CAS  Google Scholar 

  49. Gille L, Nohl H. The ubiquinol/bc1 redox couple regulates mitochondrial oxygen radical formation. Arch Biochem Biophys. 2001;388:34–8.

    PubMed  Article  CAS  Google Scholar 

  50. Ohashi T, Mizutani A, Murakami A, Kojo S, Ishii T, Taketani S. Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett. 2002;511:21–7.

    PubMed  Article  CAS  Google Scholar 

  51. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med. 2007;43:995–1022.

    PubMed  Article  CAS  Google Scholar 

  52. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem. 2003;278:36027–31.

    PubMed  Article  CAS  Google Scholar 

  53. Arnould D, Akarid K, Grodet A, Petit PX, Estaquier J, Ameisen JC. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 2002;9:65–81.

    Article  Google Scholar 

  54. Luque-Ortega JR, Martinez S, Saugar JM, et al. Fungus-elicited metabolites from plants as an enriched source for new leishmanicidal agents: antifungal phenyl-phenalenone phytoalexins from the banana plant (Musa acuminata) target mitochondria of Leishmania donovani promastigotes. Antimicrob Agents Chemother. 2004;48:1534–40.

    PubMed  Article  CAS  Google Scholar 

  55. Roy A, Ganguly A, BoseDasgupta S, et al. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3′diindolylmethane through inhibition of F1F0-ATP synthase in unicellular protozoa parasite Leishmania donovani. Mol Pharmacol. 2008;74:1292–307.

    PubMed  Article  CAS  Google Scholar 

  56. Cavalli A, Bolognesi ML. Neglected tropical diseases: Multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania. Med Chem Perpectives. 2009;52:7339–59.

    Article  CAS  Google Scholar 

  57. Urbina JA, Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 2003;19:495–501.

    PubMed  Article  CAS  Google Scholar 

  58. Paulino M, Iribarne F, Dubin M, Aguilera-Morales S, Tapia O, Stoppani AO. The chemotherapy of Chagas’ disease: an overview. Mini-Rev Med Chem. 2005;5:499–519.

    PubMed  Article  CAS  Google Scholar 

  59. Boiani M, Piacenza L, Hernández P, Boiani L, Cerecetto H, González M, et al. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved? Biochem Pharmacol. 2010;79:1736–45.

    PubMed  Article  CAS  Google Scholar 

  60. Jones SM, Urch JE, Brun R, Harwood JL, Berry C, Gilbert IH. Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents. Bioorg Med Chem. 2004;12:683–92.

    PubMed  Article  CAS  Google Scholar 

  61. Shapiro TA, Klein VA, Englund PT. Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria. J Biol Chem. 1989;264:4173–8.

    PubMed  CAS  Google Scholar 

  62. Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, de Castro SL. Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. J Antimicrob Chemother. 2005;55:780–4.

    PubMed  Article  CAS  Google Scholar 

  63. Batista Dda G, Batista MM, de Oliveira GM, et al. Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas’ disease treatment. Antimicrob Agents Chemother. 2010;54:2940–52.

    PubMed  Article  Google Scholar 

  64. Bernacchi AS, Franke DC, Castro JA. Trypanocidal action of 2,4-dichloro-6-phenylphenoxyethyl diethylamine hydrobromide (Lilly 18947) on Trypanosoma cruzi. Acta Pharmacol Sin. 2002;23:399–404.

    PubMed  CAS  Google Scholar 

  65. Menna-Barreto RF, Henriques-Pons A, Pinto AV, et al. Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. J Antimicrob Chemother. 2005;56:1034–41.

    PubMed  Article  CAS  Google Scholar 

  66. De Carvalho EA, Andrade PP, Silva NH, Pereira EC, Figueiredo RC. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. Micron. 2005;36:155–61.

    PubMed  Article  Google Scholar 

  67. Deolindo P, Teixeira-Ferreira AS, Melo EJ, et al. Programmed cell death in Trypanosoma cruzi induced by Bothrops jararaca venom. Mem Inst Oswaldo Cruz. 2005;100:33–8.

    PubMed  Article  Google Scholar 

  68. Adade CM, Cons BL, Melo PA, Souto-Padrón T. Effect of Crotalus viridis viridis snake venom on the ultrastructure and intracellular survival of Trypanosoma cruzi. Parasitology. 2011;138:46–58.

    PubMed  Article  CAS  Google Scholar 

  69. Veiga-Santos P, Pelizzaro-Rocha KJ, Santos AO, et al. In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea. Parasitology. 2010;137:1661–70.

    PubMed  Article  CAS  Google Scholar 

  70. Fairlamb AH. Chemotherapy of human African trypanosomiasis: current and future prospect. Trends Parasitol. 2003;19:488–94.

    PubMed  Article  CAS  Google Scholar 

  71. Delexpaux V, de Koning HP. Drugs and drug resistance in African trypanosomiasis. Drug Resist Update. 2007;10:30–50.

    Article  Google Scholar 

  72. Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis. 1985;7:625–34.

    PubMed  Article  CAS  Google Scholar 

  73. Berger B, Carter NS, Fairlamb AH. Characterization of pentamidine-resistant Trypanosma brucei brucei. Mol Biochem Parasitol. 1995;69:289–98.

    PubMed  Article  CAS  Google Scholar 

  74. Basselin M, Badet-Denisot MA, Lawrence F, Robert-Gero M. Effects of pentamidine on polyamine levels and biosynthesis in wild type, pentamidine-treated and pentamidine resistant Leishmania. Exp Parasitol. 1997;85:274–82.

    PubMed  Article  CAS  Google Scholar 

  75. Mukherjee A, Padmanabhan PK, Sahani MH, Barrett MP, Madhubala R. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani. Mol Biochem Parasitol. 2006;145:1–10.

    PubMed  Article  CAS  Google Scholar 

  76. Lanteri CA, Tidwell RR, Meshnick SR. The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei. Antimicrob Agents Chemother. 2008;52:875–82.

    PubMed  Article  CAS  Google Scholar 

  77. Yabu Y, Yoshida A, Suzuki T, et al. The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice. Parasitol Int. 2003;52:155–64.

    PubMed  Article  CAS  Google Scholar 

  78. Yabu Y, Suzuki T, Nihei C, et al. Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol. Parasitol Int. 2006;55:39–43.

    PubMed  Article  CAS  Google Scholar 

  79. Vodnala SK, Ferella M, Lundén-Miguel H, et al. Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin. PLoS Negl Trop Dis. 2009;3:e495.

    PubMed  Article  Google Scholar 

  80. Mamani-Matsuda M, Rambert J, Malvy D, et al. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob Agents Chemother. 2004;48:924–9.

    PubMed  Article  CAS  Google Scholar 

  81. Mittra B, Saha A, Chowdhury AR, et al. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med. 2000;6:527–41.

    PubMed  Article  CAS  Google Scholar 

  82. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, Nakhasi HL. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 2002;9:53–64.

    PubMed  Article  CAS  Google Scholar 

  83. Luque-Ortega JR, Reuther P, Rivas L, Dardonville C. New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II. J Med Chem. 2010;53:1788–98.

    PubMed  Article  CAS  Google Scholar 

  84. Sen R, Bandyopadhyay S, Dutta A, et al. Artemisinin triggers induction of cell-arrest and apoptosis in Leishmania donovani promastigotes. J Med Microbiol. 2007;56:1213–8.

    PubMed  Article  CAS  Google Scholar 

  85. Mishina YV, Krishna S, Haynes RK, Meade JC. Artemisinins inhibited Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrobial Agents Chemother. 2007;51:1852–4.

    Article  CAS  Google Scholar 

  86. Cauchetier E, Loiseau PM, Lehman J, et al. Characterization of atovaquone resistance in Leishmania infantum promastigotes. Int J Parasitol. 2002;32:1043–51.

    PubMed  Article  CAS  Google Scholar 

  87. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol. 1999;33:704–11.

    PubMed  Article  CAS  Google Scholar 

  88. Hughes LM, Lanteri CA, O’Neil MT, Johnson JD, Gribble GW, Trumpower BL. Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance. Mol Biochem Parasitol. 2011;177:12–9.

    PubMed  Article  CAS  Google Scholar 

  89. Chen M, Zhai L, Christensen SB, Theander TG, Kharazmi A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother. 2001;45:2023–9.

    PubMed  Article  CAS  Google Scholar 

  90. Kayser O, Chen M, Kharazmi A, Kiderlen AF. Aurones interfere with Leishmania major mitochondrial fumarate reductase. Z Naturforsch C. 2002;57:717–20.

    PubMed  CAS  Google Scholar 

  91. Carvalho L, Luque-Ortega JR, Manzano JI, Castanys S, Rivas L, Gamarro F. Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis. Antimicrob Agents Chemother. 2010;54:5344–51.

    PubMed  Article  CAS  Google Scholar 

  92. Dutta A, Ghoshal A, Mandal D, et al. Racemoside A, an anti-leishmanial, water soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani. J Med Microbiol. 2007;56:1196–204.

    PubMed  Article  CAS  Google Scholar 

  93. Sen N, Banerjee B, Das BB, et al. Aposptosis is induced in leishmania cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex. Cell Death Differ. 2007;14:358–67.

    PubMed  Article  CAS  Google Scholar 

  94. Misra P, Kumar A, Khare P, Gupta S, Kumar N, Dube A. Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol. J Med Microbiol. 2009;58:1058–66.

    PubMed  Article  CAS  Google Scholar 

  95. Saha P, Sen R, Hariharan C, Kumar D, Das P, Chatterjee M. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res. 2009;43:1101–10.

    PubMed  Article  CAS  Google Scholar 

  96. Reimó JQ, Taniwaki NN, Tempone AG. Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study. Parasitol Res. 2010;106:1465–9.

    Article  Google Scholar 

  97. Tempone AG, da Silva AC, Brandt CA, et al. Synthesis and antileishmanial activities of novel 3-substituted quinolines. Antimicrob Agents Chemother. 2005;49:1076–80.

    PubMed  Article  CAS  Google Scholar 

  98. Rodrigues JC, Bernardes CF, Visbal G, et al. Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist. 2007;158:447–56.

    PubMed  Article  CAS  Google Scholar 

  99. Magan R, Marin C, Rosales MJ, Salas JM, Sanchez-Moreno M. Therapeutic potential of new Pt(II) and Ru(III) triazole-pyrimidine complexes against Leishmania donovani. Pharmacol. 2005;3:41–8.

    Google Scholar 

  100. Sen N, Das BB, Ganguly A, Banerjee B, Sen T, Majumder HK. Leishmania donovani: intracellular ATP level regulates apoptosis-like death in luteolin induced dyskinetoplastid cells. Exp Parasitol. 2006;114:204–14.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Departamento de Parasitología, Instituto de Medicina Tropical “Pedro Kourí”, Apartado Postal No. 601, Marianao 13, Ciudad Habana, Cuba

    Lianet Monzote Fidalgo

  2. Institute of Pharmacology and Toxicology Department of Biomedical Sciences, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria

    Lars Gille

Authors
  1. Lianet Monzote Fidalgo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lars Gille
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lianet Monzote Fidalgo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fidalgo, L.M., Gille, L. Mitochondria and Trypanosomatids: Targets and Drugs. Pharm Res 28, 2758 (2011). https://doi.org/10.1007/s11095-011-0586-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11095-011-0586-3

KEY WORDS

  • drug
  • Leishmania
  • mitochondria
  • target
  • Trypanosoma